Considering the association of BCR-ABL and CCND1 expression with the promotion of angiogenesis, miR-342-5p may indirectly affect the ability of the CML periphery to undergo angiogenesis through the inhibition of these two targets [68–70]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.